Literature DB >> 16733866

Study on biological characters of SGC7901 gastric cancer cell-dendritic cell fusion vaccines.

Kun Zhang1, Peng-Fen Gao, Pei-Wu Yu, Yun Rao, Li-Xin Zhou.   

Abstract

AIM: To detect the biological characters of the SGC7901 gastric cancer cell-dendritic cell fusion vaccines.
METHODS: The suspending living SGC7901 gastric cancer cells and dendritic cells were induced to be fusioned by polyethylene glycol. Pure fusion cells were obtained by selective culture with the HAT/HT culture systems. The fusion cells were counted at different time points of culture and their growth curves were drawn to reflect their proliferative activities. The fusion cells were also cultured in culture medium to investigate whether they could grow into cell clones. MTT method was used to test the stimulating abilities of the fusion cells on T lymphocytes' proliferations. Moreover, the fusion cells were planted into nude mice to observe whether they could grow into new planted tumors in this kind of immunodeficiency animals.
RESULTS: The fusion cells had weaker proliferative activity and clone abilities than their parental cells. When they were cultured, the counts of cells did not increase remarkably, nor could they grow into cell clones in culture medium. The fusion cells could not grow into new planted tumors after planted into nude mice. The stimulating abilities of the fusion cells on T lymphocytes' proliferations were remarkably increased than their parental dendritic cells.
CONCLUSION: The SGC7901 gastric cancer cell-dendritic cell fusion vaccines have much weaker proliferative abilities than their parental cells, but they keep strong abilities to irritate the T lymphocytes and have no abilities to grow into new planted tumors in immunodeficiency animals. These are the biological basis for their anti-tumor biotherapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733866      PMCID: PMC4087880          DOI: 10.3748/wjg.v12.i21.3438

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway.

Authors:  Z You; X F Huang; J Hester; L Rollins; C Rooney; S Y Chen
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

2.  Role of Fas and granule exocytosis pathways in tumor-infiltrating T lymphocyte-induced apoptosis of autologous human lung-carcinoma cells.

Authors:  G Dorothee; M Ameyar; A Bettaieb; I Vergnon; H Echchakir; M Bouziane; S Chouaib; F Mami-Chouaib
Journal:  Int J Cancer       Date:  2001-03-15       Impact factor: 7.396

Review 3.  Co-stimulation and modulation of the ensuing immune response.

Authors:  C J Howard; J C Hope; S A Stephens; D R Gliddon; G P Brooke
Journal:  Vet Immunol Immunopathol       Date:  2002-09-10       Impact factor: 2.046

4.  Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids.

Authors:  A Kugler; G Stuhler; P Walden; G Zöller; A Zobywalski; P Brossart; U Trefzer; S Ullrich; C A Müller; V Becker; A J Gross; B Hemmerlein; L Kanz; G A Müller; R H Ringert
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

5.  Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA.

Authors:  E Eppler; H Hörig; H L Kaufman; P Groscurth; L Filgueira
Journal:  Eur J Cancer       Date:  2002-01       Impact factor: 9.162

6.  Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine.

Authors:  R J Orentas; D Schauer; Q Bin; B D Johnson
Journal:  Cell Immunol       Date:  2001-10-10       Impact factor: 4.868

7.  Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.

Authors:  P Brossart; S Wirths; G Stuhler; V L Reichardt; L Kanz; W Brugger
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

8.  Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector.

Authors:  D S Steinwaerder; C A Carlson; D L Otto; Z Y Li; S Ni; A Lieber
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

9.  The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.

Authors:  K Y Tsang; M Zhu; J Even; J Gulley; P Arlen; J Schlom
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

10.  Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity.

Authors:  Yongqing Liu; Weidong Zhang; Tim Chan; Anurag Saxena; Jim Xiang
Journal:  Leuk Res       Date:  2002-08       Impact factor: 3.156

View more
  1 in total

Review 1.  Could gastrointestinal tumor-initiating cells originate from cell-cell fusion in vivo?

Authors:  Yang Zhou; Jun-Ting Cheng; Zi-Xian Feng; Ying-Ying Wang; Ying Zhang; Wen-Qi Cai; Zi-Wen Han; Xian-Wang Wang; Ying Xiang; Hui-Yu Yang; Bing-Rong Liu; Xiao-Chun Peng; Shu-Zhong Cui; Hong-Wu Xin
Journal:  World J Gastrointest Oncol       Date:  2021-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.